http://www.mmm-online.com Latest articles from Medical Marketing and Media Industry News MMM Industry News The latest news from the healthcare marketing and communications sector involving pharmaceutical, biotech and medical device companies. Industry News mmmsubs@haymarketmedia.com no InVentiv Health acquired ParagonRx, a consulting company specializing in pharma risk management and optimizing medication use. The acquisition is aimed at bolstering inVentiv's Risk Evaluation and Mitigation Strategy offering . In the past year, the network noted, more than a quarter of all new drug approvals in the US included an FDA-approved REMS program. http://www.mmm-online.com/company-news-inventiv-health/article/160659/ Tue, 05 Jan 2010 19:08:37 GMT InVentiv Health acquired ParagonRx, a consulting company specializing in pharma risk management and optimizing medication use. The acquisition is aimed at bolstering inVentiv's Risk Evaluation and Mitigation Strategy offering . In the past year, the network noted, more than a quarter of all new drug approvals in the US included an FDA-approved REMS program. MMM Arguing that most Americans don't know about the FDA's adverse events reporting program, Consumers Union said DTC ads should include a toll-free number that patients can use to report side effects to the FDA. http://www.mmm-online.com/watchdogs-want-fda-number-in-ads/article/109657/ Thu, 01 May 2008 19:47:00 GMT Arguing that most Americans don't know about the FDA's adverse events reporting program, Consumers Union said DTC ads should include a toll-free number that patients can use to report side effects to the FDA. MMM The American Medical Association announced it is partnering with Sermo, the online community for physicians. http://www.mmm-online.com/ama-hooks-up-online-with-sermo/article/24165/ Tue, 05 Jun 2007 04:00:00 GMT The American Medical Association announced it is partnering with Sermo, the online community for physicians. MMM GlaxoSmithKline is in Congressional crosshairs over its marketing of Avandia, and investors arent happy either. http://www.mmm-online.com/glaxosmithkline-faces-more-avandia-fallout/article/24166/ Tue, 05 Jun 2007 04:00:00 GMT GlaxoSmithKline is in Congressional crosshairs over its marketing of Avandia, and investors arent happy either. MMM Lyons Lavey Nickel Swift is rebranding as “LyonHeart” under its proprietary creative-strategic process dubbed “Disruption.” http://www.mmm-online.com/llns-rebrands-as-lyonheart/article/24164/ Tue, 05 Jun 2007 04:00:00 GMT Lyons Lavey Nickel Swift is rebranding as “LyonHeart” under its proprietary creative-strategic process dubbed “Disruption.” MMM Onyx and Bayers kidney cancer drug Nexavar (sorafenib) was also found to extend the lives of liver cancer patients in a clinical trial by almost three months, or 44%, doctors said. http://www.mmm-online.com/nexavar-also-seen-as-liver-cancer-breakthrough/article/24159/ Mon, 04 Jun 2007 04:00:00 GMT Onyx and Bayers kidney cancer drug Nexavar (sorafenib) was also found to extend the lives of liver cancer patients in a clinical trial by almost three months, or 44%, doctors said. MMM InVentiv Health has acquired brand identity shop Addison Whitney. http://www.mmm-online.com/inventiv-buys-brand-id-shop-addison-whitney/article/24148/ Thu, 31 May 2007 04:00:00 GMT InVentiv Health has acquired brand identity shop Addison Whitney. MMM The FDA will convene a joint panel of outside experts to examine the risks and benefits of Sanofi-Aventis’ antibiotic Ketek (telithromycin). http://www.mmm-online.com/panel-to-review-sanofi-aventis-ketek/article/23673/ Wed, 15 Nov 2006 20:32:00 GMT The FDA will convene a joint panel of outside experts to examine the risks and benefits of Sanofi-Aventis’ antibiotic Ketek (telithromycin). MMM The FDA will convene a joint panel of outside experts to examine the risks and benefits of Sanofi-Aventis’ antibiotic Ketek (telithromycin). http://www.mmm-online.com/panel-to-review-sanofi-aventis-ketek/article/23672/ Wed, 15 Nov 2006 20:32:00 GMT The FDA will convene a joint panel of outside experts to examine the risks and benefits of Sanofi-Aventis’ antibiotic Ketek (telithromycin). MMM Pfizer won’t be allowed to present new data on its closely watched developmental drug torcetrapib at the annual American Heart Association (AHA) meeting this week. http://www.mmm-online.com/aha-forbids-pfizer-from-presenting-torcetrapib-results/article/23666/ Wed, 15 Nov 2006 00:15:00 GMT Pfizer won’t be allowed to present new data on its closely watched developmental drug torcetrapib at the annual American Heart Association (AHA) meeting this week. MMM Novartis has asked the FDA to extend the review period for its highly anticipated developmental diabetes drug Galvus by three months to allow the agency to examine new clinical trials data. http://www.mmm-online.com/novartis-asks-fda-for-galvus-review-extension/article/23665/ Wed, 15 Nov 2006 00:13:00 GMT Novartis has asked the FDA to extend the review period for its highly anticipated developmental diabetes drug Galvus by three months to allow the agency to examine new clinical trials data. MMM Genentech has agreed to acquire its Xolair co-marketer, the Houston-based biotech firm Tanox, in a deal worth $919 million. http://www.mmm-online.com/genentech-acquires-xolair-partner-tanox/article/23658/ Fri, 10 Nov 2006 19:00:00 GMT Genentech has agreed to acquire its Xolair co-marketer, the Houston-based biotech firm Tanox, in a deal worth $919 million. MMM 3M has agreed to sell-off its global pharmaceuticals business, which makes dermatology, women’s health, cardiology and respiratory treatments, for $2.1 billion. http://www.mmm-online.com/3m-sheds-pharma-unit-for-21-billion/article/23657/ Thu, 09 Nov 2006 23:43:00 GMT 3M has agreed to sell-off its global pharmaceuticals business, which makes dermatology, women’s health, cardiology and respiratory treatments, for $2.1 billion. MMM Abbott has agreed to buy specialty firm Kos for $3.7 billion, a move that complements its cardiovascular franchise and boosts its pipeline. http://www.mmm-online.com/abbott-to-buy-kos-for-37-billion/article/23654/ Tue, 07 Nov 2006 23:56:00 GMT Abbott has agreed to buy specialty firm Kos for $3.7 billion, a move that complements its cardiovascular franchise and boosts its pipeline. MMM The prices being paid in the recent rash of pharmaceutical acquisition deals are “breath-taking,” Schering-Plough CEO Fred Hassan said in an interview with Marketwatch.com. http://www.mmm-online.com/schering-plough-ceo-calls-takeover-prices-breath-taking/article/23653/ Tue, 07 Nov 2006 23:53:00 GMT The prices being paid in the recent rash of pharmaceutical acquisition deals are “breath-taking,” Schering-Plough CEO Fred Hassan said in an interview with Marketwatch.com. MMM The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said. http://www.mmm-online.com/lilly-bms-part-of-california-investigation-of-anti-psychotics/article/23651/ Tue, 07 Nov 2006 23:49:00 GMT The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said. MMM Pfizer confirmed that its leading pipeline candidate torcetrapib raised blood pressure in clinical trial patients more than previously reported. http://www.mmm-online.com/trial-results-cloud-future-of-pfizers-torcetrapib/article/23650/ Tue, 07 Nov 2006 23:47:00 GMT Pfizer confirmed that its leading pipeline candidate torcetrapib raised blood pressure in clinical trial patients more than previously reported. MMM The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said. http://www.mmm-online.com/lilly-bms-part-of-california-investigation-of-anti-psychotics/article/23644/ Tue, 07 Nov 2006 02:55:00 GMT The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said. MMM Behavioral change-focused relationship marketing firm HealthMedia announced today that it has acquired the consumer Web site MySelfHelp.com. http://www.mmm-online.com/healthmedia-acquires-myselfhelpcom/article/23643/ Thu, 02 Nov 2006 00:19:00 GMT Behavioral change-focused relationship marketing firm HealthMedia announced today that it has acquired the consumer Web site MySelfHelp.com. MMM Nearly 40% of scientists researching diseases and cures at the National Institutes of Health (NIH) are considering new jobs to escape strict ethics rules, a recent survey said. http://www.mmm-online.com/nih-scientists-seeking-new-work-in-wake-of-tougher-disclosure-rules/article/23629/ Tue, 31 Oct 2006 00:03:00 GMT Nearly 40% of scientists researching diseases and cures at the National Institutes of Health (NIH) are considering new jobs to escape strict ethics rules, a recent survey said. MMM